TONON, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 1.832
EU - Europa 737
AS - Asia 647
SA - Sud America 155
AF - Africa 37
OC - Oceania 5
Totale 3.413
Nazione #
US - Stati Uniti d'America 1.800
IT - Italia 345
SG - Singapore 248
HK - Hong Kong 181
CN - Cina 141
BR - Brasile 136
DE - Germania 95
NL - Olanda 50
FI - Finlandia 35
FR - Francia 34
GB - Regno Unito 34
PL - Polonia 32
SE - Svezia 27
RU - Federazione Russa 24
IN - India 15
CA - Canada 11
TR - Turchia 10
VN - Vietnam 10
AR - Argentina 9
ES - Italia 9
ZA - Sudafrica 9
IE - Irlanda 8
AT - Austria 7
CI - Costa d'Avorio 6
IR - Iran 6
MX - Messico 6
AL - Albania 5
EG - Egitto 5
JP - Giappone 5
UA - Ucraina 5
EC - Ecuador 4
JM - Giamaica 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
BD - Bangladesh 3
BE - Belgio 3
CZ - Repubblica Ceca 3
LV - Lettonia 3
MA - Marocco 3
SI - Slovenia 3
AF - Afghanistan, Repubblica islamica di 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
GE - Georgia 2
IS - Islanda 2
KG - Kirghizistan 2
MR - Mauritania 2
NE - Niger 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
UZ - Uzbekistan 2
BH - Bahrain 1
BS - Bahamas 1
CD - Congo 1
CH - Svizzera 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KY - Cayman, isole 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NA - Namibia 1
NC - Nuova Caledonia 1
NP - Nepal 1
PA - Panama 1
PF - Polinesia Francese 1
PH - Filippine 1
PW - Palau 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
Totale 3.413
Città #
Fairfield 306
Hong Kong 181
Singapore 155
Ashburn 134
Woodbridge 131
Chandler 126
Seattle 112
Cambridge 111
Houston 109
Ann Arbor 96
Wilmington 79
Boardman 54
Munich 49
Padova 46
Santa Clara 46
Beijing 37
San Diego 34
Bytom 30
Medford 26
Princeton 26
Roxbury 22
Des Moines 21
Milan 21
Rome 17
São Paulo 16
Helsinki 14
Turku 14
Legnaro 13
Düsseldorf 11
Los Angeles 11
Nanjing 11
New York 11
Chicago 10
Dong Ket 10
Bologna 9
London 9
Nuremberg 9
Cagliari 8
Guangzhou 8
Rio de Janeiro 8
Johannesburg 7
Turin 7
Abidjan 6
Catania 6
Dearborn 6
Dublin 6
Istanbul 6
Atlanta 5
Buenos Aires 5
Shanghai 5
Shenyang 5
Tirana 5
Vicenza 5
Agrigento 4
Bari 4
Hebei 4
Hefei 4
Madrid 4
Padua 4
Tokyo 4
Verona 4
Villafranca Padovana 4
Amsterdam 3
Ancona 3
Baku 3
Belo Horizonte 3
Brussels 3
Chennai 3
Chiswick 3
Dallas 3
Damietta 3
Guayaquil 3
Kingston 3
Lauterbourg 3
Messina 3
Palermo 3
Phoenix 3
Preganziol 3
Pune 3
Ribeirão Preto 3
Riga 3
San Francisco 3
San Jose 3
San Nicola Manfredi 3
Toronto 3
Vienna 3
Albignasego 2
Ascoli Piceno 2
Banská Štiavnica 2
Barueri 2
Bauru 2
Bishkek 2
Bo 2
Bom Despacho 2
Bra 2
Brasília 2
Cairo 2
Campinas 2
Changsha 2
Chongqing 2
Totale 2.351
Nome #
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 187
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 177
CARATTERIZZAZIONE CLINICA E PROGNOSTICA DEI PATTERNS DI SCOMPENSO DELLA CIRROSI EPATICA 170
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 149
Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome 131
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome 127
The Treatment of Hepatorenal Syndrome 116
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. 116
Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be". 114
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis 114
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever 109
Sepsis-induced acute kidney injury in patients with cirrhosis 108
Etiological cure prevents further decompensation and mortality in cirrhotic patients with ascites as the single first decompensating event 107
Can the Multidimensional Prognostic Index (MPI) be a predictive instrument for mortality in older adult liver transplant candidates? 104
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 97
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir 96
Predicting outcomes of liver transplantation in patients with NASH: pre-transplant renal function is key 94
Development and Validation of a Scoring System That Includes Corrected QT Interval For Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding 87
Cardiovascular predictors of death in patients with cirrhosis 86
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study 81
Natural history of acute kidney disease in patients with cirrhosis 78
Management of ascites and hepatorenal syndrome 77
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 69
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis 62
Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis 60
Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak 59
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury 58
Acute on chronic liver failure in cirrhosis 58
[Ascites and acute kidney injury] 56
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event 55
Changes in the epidemiology and management of bacterial infections in cirrhosis 48
EFFICACY AND SAFETY OF TREATMENT OF ACUTE NONMALIGNANT PORTAL VEIN THROMBOSIS WITH SUBCUTANEOUS FONDAPARINUX IN PATIENTS WITH CIRRHOSIS AND MARKED THROMBOCYTOPENIA 47
Efficacy and safety of treatment of acute nonmalignant portal vein thrombosis with subcutaneous fondaparinux in patients with cirrhosis and marked thrombocytopenia 45
Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences 40
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 39
Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease 37
EASL Clinical Practice Guidelines on acute-on-chronic liver failure 35
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis 32
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event 32
Don't delay: Early paracentesis can save lives in hospitalized patients with cirrhosis and ascites 24
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis 24
Real-world experience with long-term albumin in patients with cirrhosis and ascites 19
Mechanisms and treatment approaches for ACLF 19
Bacterial Infections in Cirrhosis 19
Portal Hypertension: Critical Care Considerations 15
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial 15
Recompensation of cirrhosis in candidates of transplant: Tips and tricks for delisting 14
Totale 3.506
Categoria #
all - tutte 15.557
article - articoli 15.123
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 36
Totale 30.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021422 15 17 28 19 9 10 37 26 42 62 90 67
2021/2022355 7 20 25 15 42 35 6 35 34 21 35 80
2022/2023317 51 15 3 35 44 40 8 20 40 5 45 11
2023/2024325 9 43 53 34 21 26 31 17 18 13 41 19
2024/20251.390 11 90 66 52 98 60 111 126 112 89 219 356
2025/202686 86 0 0 0 0 0 0 0 0 0 0 0
Totale 3.506